Medical Cannabis Safety Reporting: What a Physician Survey Found
medical cannabis safety reporting: A cross-sectional survey of 253 physicians in Poland found frequent clinical exposure to medical cannabis but limited formal education and uncommon cannabis-specific adverse drug reaction reporting. Knowledge of…
Canada’s Cannabis Safety Surveillance System: What Six Years of Adverse Reaction Reports Reveal
Cannabis safety pharmacovigilance in Canada from 2018 to 2024 highlights important patterns in adverse reaction reports. Most reports involve older adults using cannabis medically, with extracts frequently implicated. This surveillance data provides…
AI-Driven Pharmacovigilance of GLP-1 Receptor Agonist Side Effects
GLP-1 receptor agonist pharmacovigilance reveals patient-reported side effects not fully captured in clinical trials. AI analysis of social media data highlights real-world experiences with semaglutide and tirzepatide. This approach supports clinicians…